EGFR-TKI plus brain radiotherapy versus EGFR-TKI alone in the management of EGFR-mutated NSCLC patients with brain metastases

BACKGROUND: It has been confirmed that epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) presented better efficacy than brain radiotherapy (brain RT) in the treatment of brain metastasis (BM) in EGFR mutated NSCLC patients. However, whether the combination of EGFR-TKIs and brai...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Transl Lung Cancer Res
Hlavní autoři: Dong, Kai, Liang, Wenhua, Zhao, Shen, Guo, Minzhang, He, Qihua, Li, Caichen, Song, Haiqing, He, Jianxing, Xia, Xiaojun
Médium: Artigo
Jazyk:Inglês
Vydáno: AME Publishing Company 2019
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6626863/
https://ncbi.nlm.nih.gov/pubmed/31367540
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr.2019.06.12
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky